Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Blood Cancer Journal|February 15, 2020
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Andrzej J Jakubowiak, Philip L McCarthy, et al.
Clinical and Experimental Medicine|September 25, 2023
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working GroupHarinder Gill, Garret M K Leung, Melissa G M Ooi, et al.
Blood|March 23, 2016
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working GroupPieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, et al.
Blood|October 22, 2017
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patientsHervé Avet-Loiseau, Nizar J Bahlis, Wee-Joo Chng, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study GroupSeok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Blood Cancer Discovery|March 5, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.
Haematologica|November 4, 2017
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesSiok-Bian Ng, Tae-Hoon Chung, Seiichi Kato, et al.
Lancet (London, England)|December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialMeletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
The Journal of Infectious Diseases|January 24, 2015
Bimodal Influence of Vitamin D in Host Response to Systemic Candida Infection-Vitamin D Dose MattersJoan Hui Juan Lim, Sharada Ravikumar, Yan-Ming Wang, et al.
Blood|March 1, 2023
A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemiaVaidehi Krishnan, Florian Schmidt, Zahid Nawaz, et al.
Pageof 32